DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE

Disclosed herein are novel bifunctional compounds formed by conjugating BTK inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof. L'invention concerne de nouveaux compos...

Full description

Saved in:
Bibliographic Details
Main Authors HUO, Changxin, LIU, Huaqing, WANG, Hexiang, QI, Ruipeng, WANG, Zhiwei
Format Patent
LanguageEnglish
French
Published 06.07.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are novel bifunctional compounds formed by conjugating BTK inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof. L'invention concerne de nouveaux composés bifonctionnels formés par conjugaison de fractions d'inhibiteurs de BTK avec des fractions de ligandd de ligase E3, qui fonctionnent pour recruter des protéines ciblées sur l'ubiquitine ligase E3 pour la dégradation, ainsi que leurs procédés pour leur préparation et leurs utilisations.
Bibliography:Application Number: WO2022CN143837